Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Imperial Innovations was a leading UK technology commercialization and venture investment firm focused on building and investing in pioneering technologies from top UK universities. It played a major role in the creation and growth of numerous biotech, medtech, engineering, energy, and environmental startups. The group invested heavily in early-stage life science ventures emerging from the "Golden Triangle" universities—Imperial College London, Oxford, Cambridge, UCL—and helped bring several to late-stage development or successful exits. In recent years it transitioned into Touchstone Innovations before being acquired by IP Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Imperial Innovations.